Fluorouracil
Pricing Report NDC 68682-004-31

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Fluorouracil (NDC 68682-004-31) is $4.05886 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 21, 2015.

As a provided by Oceanside Pharmaceuticals, this medication is distributed in a 1 TUBE in 1 CARTON / 40 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$4.05886
Per GM

Effective Date
Jan 21, 2015
Billable Units
40 GM
Estimated Package Price
$162.35
Data Status
As of Jan 28, 2015
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 CARTON / 40 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $4.05776 to $4.60253 per GM. Over this 1 year and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.0578 - $4.6025
Market Volatility
13.43% Variance
Latest Trend
0.03%
Date Unit Price Unit Source Method Rate
Jan 21, 2015 $4.05886 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 17, 2014 $4.05776 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 19, 2014 $4.26169 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 22, 2014 $4.21972 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 17, 2014 $4.54185 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 20, 2014 $4.60253 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 23, 2014 $4.23831 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 18, 2014 $4.11396 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 21, 2014 $4.06636 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 23, 2014 $4.09678 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 19, 2014 $4.14570 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 19, 2014 $4.17724 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 22, 2014 $4.21833 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 18, 2013 $4.21794 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 21, 2013 $4.06882 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026